Amgen beat Q1 estimates with strong margins driven by Blincyto, Prolia, and standout Imdelltra growth, plus strength in ...

(100%) in the 180mg cohort achieved a clinical response Tryptase levels below the lower limit of quantification observed in ...

A new explanation for why some people are in long-term pain says it could be caused by the immune system attacking the person ...

Scientists have discovered a unique class of small antibodies that are strongly protective against a wide range of SARS ...

Tiziana (TLSA) is showing groundbreaking advancements in Alzheimer's & MS treatments with foralumab. Key trials & market ...

SII and DNDi will develop a work plan to implement research and development, Phase 3 clinical trials, and access activities, along with a joint strategy to raise the necessary funds and resources ...

The Serum Institute of India collaborates with the Drugs for Neglected Diseases initiative to develop a monoclonal antibody ...

The FDA has approved Enflonsia (clesrovimab-cfor) for the prevention of RSV lower respiratory tract disease in neonates and ...

Discover the new migraine medications, such as monoclonal antibodies and gepants, that are changing migraine treatment for ...

BioNTech is acquiring CureVac in a deal that brings messenger RNA manufacturing capability and cancer immunotherapy ...

Vice Chancellor Morgan T. Zurn for the second time found Alexion liable to Shareholder Representative Services, the Quinn ...

After dropping its only clinical-stage candidate last month, ADC Therapeutics is shutting down a U.K. research site and ...